Stock ROVI LABORATORIOS FARMACEUTICOS ROVI, S.A.
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Editorial Features Laboratorios Farmaceuticos Rovi, S.A.

Equities

ROVI

ES0157261019

Market Closed - BME
Other stock markets
 11:35:03 2024-05-14 am EDT 		Pre-market 02:41:22 am
84.4 EUR -0.18% Intraday chart for Laboratorios Farmaceuticos Rovi, S.A. 84.62 +0.27%
May. 08 Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 02 Spain's Rovi Obtains US FDA Approval for Marketing Risvan as Schizophrenia Treatment MT

MarketScreener Editorial Features

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Global markets live: Macy's, Salesforce, Dollar General, Nordstrom, Exxon...Global markets live: Macy's, Salesforce, Dollar General, Nordstrom, Exxon... June 01, 2023 at 11:48 am EDT
Alert: New entry in the European portfolioAlert: New entry in the European portfolio August 30, 2021 at 05:57 am EDT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ROVI Stock
  4. News Laboratorios Farmaceuticos Rovi, S.A.
  5. MarketScreener Editorial Features
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW